Literature DB >> 15690148

A functional CD40 receptor is expressed in pancreatic beta cells.

D Klein1, F Barbé-Tuana, A Pugliese, H Ichii, D Garza, M Gonzalez, R D Molano, C Ricordi, R L Pastori.   

Abstract

AIMS/HYPOTHESIS: Despite differences in function and embryonic origin, pancreatic islet cells and neurons express proteins belonging to the tumour necrosis factor receptor superfamily. While neurons express the CD40 receptor, it is unknown whether islet cells also express it. We investigated CD40 expression in human and mouse pancreatic islets as well as in NIT-1 insulinoma cells.
METHODS: CD40 expression was studied by reverse transcriptase polymerase chain reaction, flow cytometry, immunohistochemistry and western blot. Responses mediated by CD40 were assessed by a luciferase gene reporter assay following stimulation with a CD40 agonist antibody.
RESULTS: We found that CD40 is expressed in mouse and human pancreatic islet cells. CD40 is expressed by beta cells, and its expression is upregulated by proinflammatory cytokines (IL-1beta, IFN-gamma and TNF-alpha). CD40 signalling in NIT-1 insulinoma cells activates nuclear factor kappa-B, demonstrating that CD40 is functional. CONCLUSIONS/
INTERPRETATION: We present evidence that, in addition to immune cell types, mouse and human pancreatic beta cells express CD40. Its expression is upregulated by proinflammatory stimuli, and signalling through this receptor activates NF-kappaB. We suggest that the effects of inflammatory stimuli that affect beta cell function and survival may be also mediated by signalling through the CD40 receptor. Thus, CD40 may have a role in processes associated with islet autoimmunity and transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15690148     DOI: 10.1007/s00125-004-1645-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  45 in total

Review 1.  CD40 and its ligand in the regulation of humoral immunity.

Authors:  S J Klaus; I Berberich; G Shu; E A Clark
Journal:  Semin Immunol       Date:  1994-10       Impact factor: 11.130

Review 2.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

3.  Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation.

Authors:  R Bottino; L A Fernandez; C Ricordi; R Lehmann; M F Tsan; R Oliver; L Inverardi
Journal:  Diabetes       Date:  1998-03       Impact factor: 9.461

4.  CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion.

Authors:  N J Gallagher; A G Eliopoulos; A Agathangelo; J Oates; J Crocker; L S Young
Journal:  Mol Pathol       Date:  2002-04

5.  CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines.

Authors:  O Vosters; C Beuneu; N Nagy; B Movahedi; E Aksoy; I Salmon; D Pipeleers; M Goldman; V Verhasselt
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

6.  CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis.

Authors:  D G Wingett; R E Vestal; K Forcier; N Hadjokas; C P Nielson
Journal:  Breast Cancer Res Treat       Date:  1998-07       Impact factor: 4.872

7.  CD40 is functionally expressed on human thymic epithelial cells.

Authors:  A H Galy; H Spits
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

8.  CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.

Authors:  K Karmann; C C Hughes; J Schechner; W C Fanslow; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas.

Authors:  I Stamenkovic; E A Clark; B Seed
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

10.  A novel function of CD40: induction of cell death in transformed cells.

Authors:  S Hess; H Engelmann
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  11 in total

1.  Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia.

Authors:  John C Byrd; Thomas J Kipps; Ian W Flinn; Maureen Cooper; Olatoyosi Odenike; Jennifer Bendiske; John Rediske; Sanela Bilic; Jyotirmoy Dey; Johan Baeck; Susan O'Brien
Journal:  Leuk Lymphoma       Date:  2012-06-12

Review 2.  CD40 and autoimmunity: the dark side of a great activator.

Authors:  Anna L Peters; Laura L Stunz; Gail A Bishop
Journal:  Semin Immunol       Date:  2009-10       Impact factor: 11.130

3.  CD40 activation in human pancreatic islets and ductal cells.

Authors:  D Klein; F Timoneri; H Ichii; C Ricordi; R L Pastori
Journal:  Diabetologia       Date:  2008-07-26       Impact factor: 10.122

4.  Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease.

Authors:  Amanda K Huber; Fred D Finkelman; Cheuk Wun Li; Erlinda Concepcion; Eric Smith; Eric Jacobson; Rauf Latif; Mehdi Keddache; Weijia Zhang; Yaron Tomer
Journal:  J Immunol       Date:  2012-08-10       Impact factor: 5.422

5.  Characterization of pancreatic ductal cells in human islet preparations.

Authors:  Hirohito Ichii; Atsushi Miki; Toshiyuki Yamamoto; Ruth D Molano; Scott Barker; Atsuyoshi Mita; Rayner Rodriguez-Diaz; Dagmar Klein; Ricardo Pastori; Rodolfo Alejandro; Luca Inverardi; Antonello Pileggi; Camillo Ricordi
Journal:  Lab Invest       Date:  2008-09-08       Impact factor: 5.662

6.  Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes.

Authors:  Paola S Apaolaza; Diana Balcacean; Jose Zapardiel-Gonzalo; Grace Nelson; Nataliya Lenchik; Pouria Akhbari; Ivan Gerling; Sarah J Richardson; Teresa Rodriguez-Calvo
Journal:  Sci Adv       Date:  2021-02-24       Impact factor: 14.136

7.  Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.

Authors:  George Vlad; Vivette D D'Agati; Qing-Yin Zhang; Zhuoru Liu; Eric K Ho; Thalachallour Mohanakumar; Mark A Hardy; Raffaello Cortesini; Nicole Suciu-Foca
Journal:  Diabetes       Date:  2008-04-16       Impact factor: 9.461

8.  Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation.

Authors:  Marta Bagnati; Babatunji W Ogunkolade; Catriona Marshall; Carmen Tucci; Katie Hanna; Tania A Jones; Marco Bugliani; Belinda Nedjai; Paul W Caton; Julius Kieswich; Muhammed M Yaqoob; Graham R Ball; Piero Marchetti; Graham A Hitman; Mark D Turner
Journal:  Cell Death Dis       Date:  2016-08-11       Impact factor: 8.469

9.  Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.

Authors:  Sophie Doublier; Cristina Zennaro; Luca Musante; Tiziana Spatola; Giovanni Candiano; Maurizio Bruschi; Luca Besso; Massimo Cedrino; Michele Carraro; Gian Marco Ghiggeri; Giovanni Camussi; Enrico Lupia
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

10.  Intrapancreatic injection of human bone marrow-derived mesenchymal stem/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice.

Authors:  Norimitsu Murai; Hirokazu Ohtaki; Jun Watanabe; Zhifang Xu; Shun Sasaki; Kazumichi Yagura; Seiji Shioda; Shoichiro Nagasaka; Kazuho Honda; Masahiko Izumizaki
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.